Literature DB >> 1993355

Hepatitis B surface antigen induces an early-type hypersensitivity.

H Y Lei1, J Y Wang, T T Chang, C C Wang.   

Abstract

In addition to the delayed-type hypersensitivity (DTH), a unique type of hypersensitivity could be induced at a late stage of the immune responses after hepatitis B surface antigen (HBsAg) immunization. This antigen-specific ear swelling that develops within 1 h after antigen challenge has been referred to as the early-type hypersensitivity (ETH) in contrast to the 24-h DTH. Although expression of ETH was earlier than DTH, the induction of the former needed 3 days longer than that of the latter. In ETH, the plasma protein leaked into the tissue and the vasopermeability increased within 15 min, causing the oedema of ETH. The observation that cyproheptadine, not dexamethasone, inhibited ETH suggests that it is mediated through the release of histamine and/or serotonin. Furthermore, ETH could be transferred by immune sera. Heat treatment (56 C for 4 h) did not destroy the transfer, suggesting that it was not mediated by IgE. The human anti-HBs sera from either hepatitis B virus infection or HBsAg vaccinee also contained the activity to transfer the ETH in mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993355      PMCID: PMC1535262          DOI: 10.1111/j.1365-2249.1991.tb05616.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities.

Authors:  H Van Loveren; P W Askenase
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

2.  The labelling of galactose residues in hepatitis B surface antigen glycoprotein.

Authors:  J Skelly; C R Howard; A J Zuckerman
Journal:  J Gen Virol       Date:  1978-12       Impact factor: 3.891

3.  Igh allotype-linked control of immune complex-type hypersensitivity induced by hepatitis B surface antigen.

Authors:  H Y Lei; S C Lee
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

4.  An early component of delayed-type hypersensitivity mediated by T cells and mast cells.

Authors:  H van Loveren; R Meade; P W Askenase
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

5.  Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.

Authors:  D R Milich; F V Chisari
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

6.  Induction of a delayed type hypersensitivity to carrageenin in mice.

Authors:  S Yoshino; K Ohuchi; S Tsurufuji
Journal:  J Pharmacobiodyn       Date:  1982-04

Review 7.  Type B hepatitis: a review of current prospects for a safe and effective vaccine.

Authors:  V J McAuliffe; R H Purcell; J L Gerin
Journal:  Rev Infect Dis       Date:  1980 May-Jun

8.  Immunoregulatory pathways in adult responder mice. I. Induction of GAT-specific tolerance and suppressor T cells for cellular and humoral responses.

Authors:  M K Jenkins; H Y Lei; C Waltenbaugh; S D Miller
Journal:  Scand J Immunol       Date:  1984-06       Impact factor: 3.487

9.  Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.

Authors:  D R Milich; G G Leroux-Roels; R E Louie; F V Chisari
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

10.  Gain/loss of poly(Glu50Tyr50)/poly(Glu60Ala30Tyr10) responsiveness in the bm12 mutant strain.

Authors:  H Y Lei; R W Melvold; S D Miller; C Waltenbaugh
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.